Difference between revisions of "Team:McMasterU"

Line 1: Line 1:
−
<!--{{McMasterU}}-->
+
{{McMasterU}}
 
<html lang="en">
 
<html lang="en">
 
<head>
 
<head>
Line 170: Line 170:
  
 
<div class="dialog" id="home" title="Home">
 
<div class="dialog" id="home" title="Home">
−
   <p>HOME</p>
+
 
 +
  <img src="http://mcmastergem.com/img/Proposal-04.png" style="width974px;height:1024px;">
 +
  <h2> Project Description</h5>
 +
  <p>GI tract cancers are an enormous public health issue, and together are responsible for more deaths than any other form of cancer. One of the major difficulties with diagnosing and treating these cancers, especially when localized to the intestine, is access to the tumour - patients often do not exhibit obvious symptoms until the later stages, when treatment options are limited.
 +
  </p>
 +
 
 +
  <p>We looked into a few different ways of tackling this issue, from improving existing diagnostic methods to developing new avenues for treatment. One of the consistent themes that came up in our brainstorming process was the potential for us to use the host's cell-mediated immune response to fight cancer. Cancer immunotherapy is a rapidly growing field, and clinical trials for certain forms of leukemia are already underway.
 +
  </p>
 +
 
 +
   <p>Thus, this year, McMaster iGEM sought to augment the power of the host immune system to fight against GI tract cancers, using a specially engineered strain of commensal lactobacillus bacteria. When completed, our bacteria will be able to sense the presence of tumours in the gut, bind to specific receptors on tumour cells, and begin secreting pro-inflammatory cytokines in this tumour microenvironment. This will recruit T cells to the site of the tumour and elicit an anti-cancer response, effectively stopping the cancerous growth using the body's own toolkits. This summer, we aim to develop a proof-of-concept of our idea, and create a bacterial strain that can secrete IL-2 under tightly controlled, tumour-specific conditions
 +
  </p>
 +
 
 
</div>
 
</div>
  
Line 177: Line 188:
 
</div>
 
</div>
  
−
<!--TEST OF MODAL LINKING-->
+
<div class="dialog" id="collaborations" title="Collaborations">
 +
  <p>COLLAB</p>
 +
</div>
 +
 
 +
<div class="dialog" id="description" title="Description">
 +
  <p>DESC</p>
 +
</div>
 +
 
 +
<div class="dialog" id="experiments" title="Experiments">
 +
  <p>EXP</p>
 +
</div>
 +
 
 +
<div class="dialog" id="results" title="Results">
 +
  <p>RES</p>
 +
</div>
 +
 
 +
<div class="dialog" id="notebook" title="Notebook">
 +
  <p>TEAM</p>
 +
</div>
 +
 
 +
<div class="dialog" id="parts" title="Parts">
 +
  <p>TEAM</p>
 +
</div>
 +
 
 +
<div class="dialog" id="bp" title="Basic Part">
 +
  <p>TEAM</p>
 +
</div>
 +
 
 +
<div class="dialog" id="cp" title="Composite Part">
 +
  <p>TEAM</p>
 +
</div>
 +
 
 +
<div class="dialog" id="safety" title="Safety">
 +
  <p>TEAM</p>
 +
</div>
 +
 
 +
<div class="dialog" id="attributions" title="Attributions">
 +
  <p>TEAM</p>
 +
</div>
 +
 
 +
<div class="dialog" id="hp" title="Human Practice">
 +
  <p>TEAM</p>
 +
</div>
 +
 
 +
<div class="dialog" id="hpsilver" title="Silver">
 +
  <p>TEAM</p>
 +
</div>
 +
 
 +
<div class="dialog" id="hpgold" title="Gold">
 +
  <p>TEAM</p>
 +
</div>
 +
 
 +
<div class="dialog" id="ip" title="Integrated Practices">
 +
  <p>TEAM</p>
 +
</div>
 +
 
 +
<div class="dialog" id="engagement" title="Engagement">
 +
  <p>TEAM</p>
 +
</div>
 +
 
 +
<div class="dialog" id="software" title="Software">
 +
  <p>TEAM</p>
 +
</div>
 +
 
 +
<!--MODAL LINKING-->
 
<script type="text/javascript">
 
<script type="text/javascript">
 
$(document).ready(function() {
 
$(document).ready(function() {
  
 
   if(window.location.href.indexOf('#dialog') != -1) {
 
   if(window.location.href.indexOf('#dialog') != -1) {
−
     $('#dialog').dialog('open');
+
     $('#home').dialog('open');
 +
  }
 +
  //
 +
  if(window.location.href.indexOf('#dialog') != -1) {
 +
    $('#collaborations').dialog('open');
 +
  }
 +
  //
 +
  if(window.location.href.indexOf('#dialog') != -1) {
 +
    $('#description').dialog('open');
 +
  }
 +
  //
 +
  if(window.location.href.indexOf('#dialog') != -1) {
 +
    $('#experiments').dialog('open');
 +
  }
 +
  //
 +
  if(window.location.href.indexOf('#dialog') != -1) {
 +
    $('#results').dialog('open');
 +
  }
 +
  //
 +
  if(window.location.href.indexOf('#dialog') != -1) {
 +
    $('#notebook').dialog('open');
 +
  }
 +
  //
 +
  if(window.location.href.indexOf('#dialog') != -1) {
 +
    $('#parts').dialog('open');
 +
  }
 +
  //
 +
  if(window.location.href.indexOf('#dialog') != -1) {
 +
    $('#bp').dialog('open');
 +
  }
 +
  //
 +
  if(window.location.href.indexOf('#dialog') != -1) {
 +
    $('#cp').dialog('open');
 +
  }
 +
  //
 +
  if(window.location.href.indexOf('#dialog') != -1) {
 +
    $('#safety').dialog('open');
 +
  }
 +
  //
 +
  if(window.location.href.indexOf('#dialog') != -1) {
 +
    $('#attributions').dialog('open');
 +
  }
 +
  //
 +
  if(window.location.href.indexOf('#dialog') != -1) {
 +
    $('#hp').dialog('open');
 +
  }
 +
  //
 +
  if(window.location.href.indexOf('#dialog') != -1) {
 +
    $('#hpsilver').dialog('open');
 +
  }
 +
  //
 +
  if(window.location.href.indexOf('#dialog') != -1) {
 +
    $('#hpgold').dialog('open');
 +
  }
 +
  //
 +
  if(window.location.href.indexOf('#dialog') != -1) {
 +
    $('#ip').dialog('open');
 +
  }
 +
  //
 +
  if(window.location.href.indexOf('#dialog') != -1) {
 +
    $('#engagement').dialog('open');
 +
  }
 +
  //
 +
  if(window.location.href.indexOf('#dialog') != -1) {
 +
    $('#software').dialog('open');
 
   }
 
   }
  

Revision as of 19:37, 12 September 2016

MENU ▤

McMasterU MGEM Team

McMasterU

Team


Project




Parts



Safety

Attributions

Human Practices





Awards

Project Description

GI tract cancers are an enormous public health issue, and together are responsible for more deaths than any other form of cancer. One of the major difficulties with diagnosing and treating these cancers, especially when localized to the intestine, is access to the tumour - patients often do not exhibit obvious symptoms until the later stages, when treatment options are limited.

We looked into a few different ways of tackling this issue, from improving existing diagnostic methods to developing new avenues for treatment. One of the consistent themes that came up in our brainstorming process was the potential for us to use the host's cell-mediated immune response to fight cancer. Cancer immunotherapy is a rapidly growing field, and clinical trials for certain forms of leukemia are already underway.

Thus, this year, McMaster iGEM sought to augment the power of the host immune system to fight against GI tract cancers, using a specially engineered strain of commensal lactobacillus bacteria. When completed, our bacteria will be able to sense the presence of tumours in the gut, bind to specific receptors on tumour cells, and begin secreting pro-inflammatory cytokines in this tumour microenvironment. This will recruit T cells to the site of the tumour and elicit an anti-cancer response, effectively stopping the cancerous growth using the body's own toolkits. This summer, we aim to develop a proof-of-concept of our idea, and create a bacterial strain that can secrete IL-2 under tightly controlled, tumour-specific conditions

TEAM

COLLAB

DESC

EXP

RES

TEAM

TEAM

TEAM

TEAM

TEAM

TEAM

TEAM

TEAM

TEAM

TEAM

TEAM

TEAM